Millennium Capital Advisors’s Merck MRK Stock Holding History

Millennium Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572K	Hold	4,450	–	–	0.31%	71
2026 Q1	$535K	Buy	4,450 +100	+2%	+$11.5K	0.33%	66
2025 Q4	$458K	Buy	4,350 +200	+5%	+$18.8K	0.27%	73
2025 Q3	$348K	Hold	4,150	–	–	0.21%	89
2025 Q2	$329K	Sell	4,150 -512	-11%	-$40.7K	0.22%	83
2025 Q1	$418K	Sell	4,662 -400	-8%	-$37.3K	0.31%	60
2024 Q4	$504K	Sell	5,062 -318	-6%	-$32.8K	0.34%	56
2024 Q3	$611K	Sell	5,380 -95	-2%	-$11.3K	0.4%	50
2024 Q2	$678K	Buy	5,475 +25	+0.5%	+$3.22K	0.45%	46
2024 Q1	$719K	Hold	5,450	–	–	0.51%	46
2023 Q4	$594K	Sell	5,450 -1,100	-17%	-$114K	0.45%	47
2023 Q3	$674K	Sell	6,550 -262	-4%	-$28.2K	0.58%	40
2023 Q2	$786K	Buy	6,812 +148	+2%	+$16.8K	0.65%	43
2023 Q1	$709K	Buy	6,664 +160	+2%	+$17.3K	0.63%	43
2022 Q4	$722K	Buy	6,504 +481	+8%	+$49.2K	0.73%	42
2022 Q3	$519K	Buy	6,023 +360	+6%	+$32.1K	0.55%	46
2022 Q2	$516K	Buy	5,663 +795	+16%	+$70.5K	0.5%	45
2022 Q1	$399K	Buy	4,868 +700	+17%	+$55.2K	0.32%	61
2021 Q4	$319K	Buy	+4,168	New	+$332K	0.25%	76

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Capital Advisors's MRK Position: Q2 2026 in Review

Millennium Capital Advisors held its Merck (MRK) position steady in Q2 2026 at 4,450 shares worth $572K. The position accounts for 0.31% of the portfolio, ranked #71.

Millennium Capital Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $786K in Q2 2023. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Millennium Capital Advisors held 4,450 shares of Merck worth $572K as of Q2 2026.
Millennium Capital Advisors left its Merck share count unchanged in Q2 2026.
Merck made up 0.31% of Millennium Capital Advisors's portfolio in Q2 2026, its #71 holding.
Millennium Capital Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
Millennium Capital Advisors's Merck position peaked at $786K in Q2 2023.
3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Millennium Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.